Psychedelics & The Texas Trip
With few effective mental health treatments available in the U.S., many people have been leaving the country to try psychedelic therapies.
Despite their potential to treat an array of conditions — from depression, PTSD, and substance use disorders — most psychedelics have been illegal in the U.S. for decades.
In this Petrie Dish three-part special series, Psychedelics and the Texas Trip, host Bonnie Petrie and reporter Robin Berghaus talk to the unlikely allies who united to pass a landmark bill, HB 1802, in the Texas Legislature that funded a psilocybin clinical trial.
They speak with experts about the science of psychedelics, potential health benefits and risks, and why most psychedelics were made illegal, which hindered research for decades.
They also explore what must happen so people living in the U.S. — who might benefit from psychedelic therapies — can safely and affordably access these treatments at home.
This series is supported by a Ferriss — UC Berkeley Psychedelic Journalism Fellowship.
Despite their potential to treat an array of conditions — from depression, PTSD, and substance use disorders — most psychedelics have been illegal in the U.S. for decades.
In this Petrie Dish three-part special series, Psychedelics and the Texas Trip, host Bonnie Petrie and reporter Robin Berghaus talk to the unlikely allies who united to pass a landmark bill, HB 1802, in the Texas Legislature that funded a psilocybin clinical trial.
They speak with experts about the science of psychedelics, potential health benefits and risks, and why most psychedelics were made illegal, which hindered research for decades.
They also explore what must happen so people living in the U.S. — who might benefit from psychedelic therapies — can safely and affordably access these treatments at home.
This series is supported by a Ferriss — UC Berkeley Psychedelic Journalism Fellowship.
Former Texas Governor Rick Perry tells the Petrie Dish team how he became an outspoken advocate for psychedelics-as-medicine.
Patients have been leaving the United States to try psychedelic therapies to treat their depression, PTSD, traumatic brain injuries, and substance use disorders. With so many patients finding relief, why do psychedelic therapies mostly remain illegal in the U.S., and how do psychedelics actually work?
In the final installment of this three-part series, Bonnie Petrie and reporter Robin Berghaus go from an isolated stretch of desert along the Rio Grande, where wild peyote grows, to the exuberant rooms at SXSW, where they consider the future of psychedelics-as-medicine, and back to the hallowed halls of the Texas Legislature, where the future of the so-called Ibogaine Bill is uncertain.